Production (Stage)
Coeptis Therapeutics Holdings, Inc.
COEP
$8.23
-$0.13-1.56%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 314.73% | -63.73% | -19.41% | -52.07% | -51.15% |
| Total Receivables | -- | -- | -- | -45.40% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 58.10% | 114.57% | 9.18% | 20.89% | 43.11% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 237.08% | -39.92% | -15.79% | -47.57% | -39.38% |
|
|
|||||
| Total Current Assets | 237.08% | -39.92% | -15.79% | -47.57% | -39.38% |
| Net Property, Plant & Equipment | -39.60% | -35.54% | 99.01% | 76.82% | 62.32% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -46.00% | -42.70% | 784.35% | 735.97% | 702.86% |
| Total Assets | 245.46% | 94.89% | 91.74% | -41.33% | -34.46% |
|
|
|||||
| Total Accounts Payable | -17.95% | -10.56% | 135.31% | 224.19% | 463.26% |
| Total Accrued Expenses | -16.22% | 32.54% | 30.90% | 211.77% | 250.73% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -15.57% | 21.44% | 31.88% | -15.91% | 44.72% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 31.40% | 51.01% | 53.94% | 44.23% | 117.34% |
|
|
|||||
| Total Current Liabilities | 31.40% | 51.01% | 53.94% | 44.23% | 117.34% |
| Long-Term Debt | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -69.12% | -69.12% | 316.33% | 316.33% | 316.33% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -67.63% | -35.53% | -14.88% | -66.21% | -79.21% |
| Total Liabilities | 18.97% | 34.18% | 43.04% | -3.38% | 8.13% |
|
|
|||||
| Common Stock & APIC | 14.43% | 12.33% | 16.08% | 26.88% | 27.70% |
| Retained Earnings | -12.50% | -12.45% | -13.90% | -21.73% | -22.76% |
| Treasury Stock & Other | 95.45% | 55.48% | 16.00% | -- | -863.89% |
| Total Common Equity | 668.00% | 291.30% | 154.88% | -117.78% | -188.69% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 668.00% | 291.30% | 154.88% | -117.78% | -188.69% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 754.30% | 375.09% | 163.22% | -112.46% | -188.69% |
|
|
|||||